Literature DB >> 7093100

Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period.

G Mancia, G Pomidossi, G Parati, G Bertinieri, G Grassi, F Navone, A Ferrari, L Gregorini, A Zanchetti.   

Abstract

1 The anti-hypertensive effect of labetalol given twice or three times daily was evaluated in ambulant subjects with essential hypertension by recording blood pressure directly for 24 h before and after 15 d of labetalol administration (daily dose 600-1800 mg). 2 Labetalol reduced 24 h systolic and diastolic blood pressures by about 20%. The reduction was evident throughout the whole 24 h period, although it was less marked during sleep. The hypotensive effect was similar when the drug was given twice or three times daily. 3 The 24 h heart rate was reduced during labetalol treatment. However, this effect was less marked than the hypotensive effect and was not present in all subjects. 4 There was a reduction in the standard deviations of blood pressure and heart rate values. However, in neither case was the coefficient of variation altered, indicating that labetalol did not have any significant effect on the shape of the 24 h blood pressure measurements.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093100      PMCID: PMC1401831          DOI: 10.1111/j.1365-2125.1982.tb01886.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.

Authors:  G Koch
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Factors determining the design and construction of a portable pressure transducer system.

Authors:  F D Stott; V G Terry; A J Honour
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

3.  The Oxford continuous blood-pressure recorder--technical and clinical evaluation.

Authors:  A D Goldberg; E B Raftery; H L Green
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

4.  Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure.

Authors:  W A Littler; A J Honour; D J Pugsley; P Sleight
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

5.  Vasoconstrictor response to simulated diving in man.

Authors:  D D Heistad; F M Abbound; J W Eckstein
Journal:  J Appl Physiol       Date:  1968-11       Impact factor: 3.531

6.  Direct arterial pressure recording in unrestricted man.

Authors:  A T Bevan; A J Honour; F H Stott
Journal:  Clin Sci       Date:  1969-04       Impact factor: 6.124

7.  The variability of arterial pressure.

Authors:  W A Littler; M J West; A J Honour; P Sleight
Journal:  Am Heart J       Date:  1978-02       Impact factor: 4.749

8.  Sleep and blood pressure.

Authors:  W A Littler; A J Honour; R D Carter; P Sleight
Journal:  Br Med J       Date:  1975-08-09

9.  Study of untreated hypertensive subjects by means of continuous intra-arterial blood pressure recordings.

Authors:  A D Goldberg; E B Raftery; P M Cashman; F D Stott
Journal:  Br Heart J       Date:  1978-06

10.  Sleep and blood pressure: further observations.

Authors:  W A Littler
Journal:  Am Heart J       Date:  1979-01       Impact factor: 4.749

View more
  2 in total

1.  Labetalol: the nineteen-eighties.

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 2.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.